Ophthalmic Plastic and Reconstructive Surgery · Portland, OR
NPI
1316332935
Since 2015
Specialty
Ophthalmic Plastic and Reconstructive Surgery
Code 207WX0200X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
3181 SW Sam Jackson Park Rd
Portland, OR, 97239
Phone (503) 494-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
474 services
Medicare patients, 2024
171
Average age 74
Drug cost, 2024
$1.3M
339 prescriptions
Company payments, 2025
$1,426
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Davin C Ashraf was code 99214 (office e&m - established), 70 times for 62 patients. In total Davin C Ashraf billed 474 services in 71 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 70 | 62 | $68.82 | $4,817 |
| 99213 Office E&M - Established | Facility | 55 | 46 | $51.98 | $2,859 |
| 92285 Standard X-ray | Facility | 34 | 34 | $2.10 | $71.32 |
| 92081 Vision, Hearing, and Speech Services | Facility | 32 | 32 | $11.01 | $352 |
| 99204 Office E&M - New | Facility | 29 | 29 | $95.28 | $2,763 |
| 15823 Skin | Facility | 14 | 14 | $608.87 | $8,524 |
| 67904 Eye | Facility | 13 | 12 | $658.90 | $8,566 |
| 67903 Eye | Facility | 13 | 12 | $489.12 | $6,359 |
| 67917 Eye | Facility | 12 | 11 | $324.50 | $3,894 |
By year: 2022 $51K for 371 services; 2023 $61K for 420 services; 2024 $76K for 474 services.
Medicare prescription drug claims, 2024
In 2024, the drug Davin C Ashraf prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 95 prescriptions and refills. In total Davin C Ashraf wrote 339 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 95 | 103 | 80 | $2,511 |
| Erythromycin Erythromycin Base | 93 | 96 | 72 | $1,799 |
| Oxycodone Hcl Generic | 33 | 33 | 31 | $54.06 |
| Tepezza Teprotumumab-Trbw | 27 | 27 | Under 11 | $1.2M |
| Celecoxib Generic | 14 | 14 | 13 | $47.57 |
Brand drugs: 110 claims; generic drugs: 229 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Davin C Ashraf $1,426 ($1,426 in general payments such as food, travel and fees) from 2 companies. The largest payer was Amgen Inc. with $1,353.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.